Developing breakthrough AXL therapeutics to improve patients' lives

Developing breakthrough AXL therapeutics to improve patients' lives
Learn About Us
Background
DecorationDecoration

Latest news

Old woman

BerGenBio is a clinical-stage biopharmaceutical company developing innovative drugs for aggressive diseases including cancer and severe respiratory infections

Recent News

BerGenBio ASA – Registration of reverse share split

BerGenBio ASA - Ex. reverse share split and change of ISIN today

BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

BerGenBio ASA - Key information relating to the reverse share split and change of ISIN

BerGenBio ASA: New share capital registered

BerGenBio ASA – Minutes from the annual general meeting 2024

BerGenBio ASA: Invitation to first quarter 2024 results webcast

BerGenBio ASA: Notice of Annual General Meeting